Skip to main content

Table 5 The prevalence of HCV antibody-positive patients sorted by their treatment method, at the end of 2018

From: 2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis

Treatment method HCV antibody-negative HCV antibody-positive Subtotal Unspecified No data available Total HCV antibody positivity rate (%)
Hemodialysis 152,905 7413 160,318 5205 28,956 194,479 4.62
Hemodiafiltration 95,677 4946 100,623 4147 16,864 121,634 4.92
Hemofiltration 8 0 8 2 2 12 0.00
Blood adsorption dialysis 995 219 1214 40 180 1434 18.04
Home hemodialysis 533 10 543 20 145 708 1.84
Peritoneal dialysis 5815 146 5961 384 2724 9069 2.45
Subtotal 255,933 12,734 268,667 9798 48,871 327,336 4.74
Unspecified/no data available 0 0 0 0 0 0  
Total 255,933 12,734 268,667 9798 48,871 327,336 4.74
  1. The data were obtained from the patient survey
  2. HCV hepatitis C virus